72 related articles for article (PubMed ID: 21150776)
1. Phase I/II study of biweekly vinorelbine and oxaliplatin as first-line treatment in patients with metastatic breast cancer.
Guerrero A; Servitja S; Rodríguez-Lescure A; Calvo L; del Barco S; Quintanar MT; Juárez JI; Gayo J; Llombart A; Tusquets I
Anticancer Drugs; 2011 Mar; 22(3):283-9. PubMed ID: 21150776
[TBL] [Abstract][Full Text] [Related]
2. A phase II study of an oxaliplatin/vinorelbine/5-fluorouracil combination in patients with anthracycline-pretreated and taxane-pretreated metastatic breast cancer.
Delozier T; Guastalla JP; Yovine A; Levy C; Chollet P; Mousseau M; Delva R; Coeffic D; Vannetzel JM; Zazzi ES; Brienza S; Cvitkovic E
Anticancer Drugs; 2006 Oct; 17(9):1067-73. PubMed ID: 17001180
[TBL] [Abstract][Full Text] [Related]
3. Vinorelbine and oxaliplatin in stage IV nonsmall cell lung cancer patients unfit for cisplatin: a single-center experience.
Mir O; Alexandre J; Ropert S; Montheil V; Martin I; Durand JP; Goldwasser F
Anticancer Drugs; 2009 Feb; 20(2):105-8. PubMed ID: 19209026
[TBL] [Abstract][Full Text] [Related]
4. Phase III study of intravenous vinorelbine in combination with epirubicin versus epirubicin alone in patients with advanced breast cancer: a Scandinavian Breast Group Trial (SBG9403).
Ejlertsen B; Mouridsen HT; Langkjer ST; Andersen J; Sjöström J; Kjaer M;
J Clin Oncol; 2004 Jun; 22(12):2313-20. PubMed ID: 15197192
[TBL] [Abstract][Full Text] [Related]
5. Liposomal pegylated doxorubicin plus vinorelbine combination as first-line chemotherapy for metastatic breast cancer in elderly women > or = 65 years of age.
Addeo R; Faiola V; Guarrasi R; Montella L; Vincenzi B; Capasso E; Cennamo G; Rotundo MS; Tagliaferri P; Caraglia M; Del Prete S
Cancer Chemother Pharmacol; 2008 Jul; 62(2):285-92. PubMed ID: 17922275
[TBL] [Abstract][Full Text] [Related]
6. Oral vinorelbine/paclitaxel combination treatment of metastatic breast cancer: a phase I study.
Delva R; Pienkowski T; Tubiana N; Vanhoefer U; Longerey B; Douville I
Cancer Chemother Pharmacol; 2007 May; 59(6):703-9. PubMed ID: 17021821
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of a combination of vinorelbine, cyclophosphamide and 5-fluorouracil in the treatment of advanced breast cancer.
Ardavanis A; Extra JM; Espié M; Cuvier C; Marty M
In Vivo; 1998; 12(5):559-62. PubMed ID: 9827368
[TBL] [Abstract][Full Text] [Related]
8. Multicenter phase II study of pegylated liposomal doxorubicin in combination with vinorelbine as first-line treatment in elderly patients with metastatic breast cancer.
Mlineritsch B; Schabel-Moser R; Andel J; Fridrik M; Moik M; Mayer P; Russ G; Rass C; Greil R;
Onkologie; 2009 Feb; 32(1-2):18-24. PubMed ID: 19209014
[TBL] [Abstract][Full Text] [Related]
9. A phase I study of UFT-oral vinorelbine in metastatic breast cancer.
Ferrero JM; Largillier R; Michel C; Amiot V; Milano G; Hébert C; Mari V; Courdi A; Figl A; Follana P; Barrière J; Chamorey E
Oncology; 2011; 81(2):73-8. PubMed ID: 21968516
[TBL] [Abstract][Full Text] [Related]
10. A phase II trial of biweekly vinorelbine and oxaliplatin in second- or third-line metastatic triple-negative breast cancer.
Zhang J; Wang L; Wang Z; Hu X; Wang B; Cao J; Lv F; Zhen C; Zhang S; Shao Z
Cancer Biol Ther; 2015; 16(2):225-32. PubMed ID: 25648299
[TBL] [Abstract][Full Text] [Related]
11. Phase I study of oral vinorelbine and capecitabine in patients with metastatic breast cancer.
Anton A; Lluch A; Casado A; Provencio M; Muñoz M; Lao J; Bermejo B; Paules AB; Gayo J; Martin M
Anticancer Res; 2010 Jun; 30(6):2255-61. PubMed ID: 20651377
[TBL] [Abstract][Full Text] [Related]
12. Vinorelbine/docetaxel combination treatment of metastatic breast cancer: a phase I study.
Bonneterre J; Campone M; Koralewski P; Blasinska-Morawiec M; Deporte-Fety R; Chatelut E; Leger F; Longerey B; Ecochard L; Douville I
Cancer Chemother Pharmacol; 2007 Aug; 60(3):365-73. PubMed ID: 17569044
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of an oxaliplatin/vinorelbine combination in patients with anthracycline- and taxane-pre-treated metastatic breast cancer.
Petit T; Benider A; Yovine A; Bougnoux P; Spaeth D; Maindrault-Goebel F; Serin D; Tigaud JD; Eymard JC; Simon H; Bertaux B; Brienza S; Cvitkovic E
Anticancer Drugs; 2006 Mar; 17(3):337-43. PubMed ID: 16520663
[TBL] [Abstract][Full Text] [Related]
14. First-line treatment with epirubicin and vinorelbine in metastatic breast cancer.
Vici P; Colucci G; Gebbia V; Amodio A; Giotta F; Belli F; Conti F; Gebbia N; Pezzella G; Valerio MR; Brandi M; Pisconti S; Durini E; Giannarelli D; Lopez M
J Clin Oncol; 2002 Jun; 20(11):2689-94. PubMed ID: 12039931
[TBL] [Abstract][Full Text] [Related]
15. Low-dose metronomic oral administration of vinorelbine in the first-line treatment of elderly patients with metastatic breast cancer.
Addeo R; Sgambato A; Cennamo G; Montella L; Faiola V; Abbruzzese A; Capasso E; Leo L; Botti G; Caraglia M; Del Prete S
Clin Breast Cancer; 2010 Aug; 10(4):301-6. PubMed ID: 20705563
[TBL] [Abstract][Full Text] [Related]
16. A phase I clinical and pharmacological study evaluating vinflunine in combination with doxorubicin as first line treatment in metastatic breast cancer.
Zaman K; Durando X; Baurain JF; Humblet Y; Mazzeo F; Bostnavaron M; Meheust N; Monnoyer-Favrel S; Machiels JP; Bauer J
Breast Cancer Res Treat; 2011 Jun; 127(3):689-96. PubMed ID: 21442199
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of vinorelbine and oxaliplatin as first-line therapy in malignant pleural mesothelioma.
Fennell DA; C Steele JP; Shamash J; Sheaff MT; Evans MT; Goonewardene TI; Nystrom ML; Gower NH; Rudd RM
Lung Cancer; 2005 Feb; 47(2):277-81. PubMed ID: 15639727
[TBL] [Abstract][Full Text] [Related]
18. Oral vinorelbine in metastatic breast cancer: a review of current clinical trial results.
Aapro M; Finek J
Cancer Treat Rev; 2012 Apr; 38(2):120-6. PubMed ID: 21742438
[TBL] [Abstract][Full Text] [Related]
19. Final safety and efficacy analysis of a phase I/II trial with imatinib and vinorelbine for patients with metastatic breast cancer.
Maass N; Schem C; Bauerschlag DO; Tiemann K; Schaefer FW; Hanson S; Muth M; Baier M; Weigel MT; Wenners AS; Alkatout I; Bauer M; Jonat W; Mundhenke C
Oncology; 2014; 87(5):300-10. PubMed ID: 25171229
[TBL] [Abstract][Full Text] [Related]
20. Biweekly docetaxel and vinorelbine as first-line chemotherapy in metastatic breast cancer.
Mayordomo JI; Milla A; Morales S; Yubero A; Lorenzo A; Baena JM; Modolell A; Sanz J; Illarramendi J; Garcia MJ; Machengs I; Burrilo MA; Tres A
Clin Breast Cancer; 2004 Jun; 5(2):131-5. PubMed ID: 15245617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
